Go to deals
Healthcare

MedAxiom has been acquired by American College of Cardiology

March 2019 — The private shareholders of MedAxiom have sold the company to American College of Cardiology, Inc.

MedAxiom was founded in 2001 and is the nation’s leading cardiovascular performance community serving physician practices by providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events to improve business and patient care outcomes.

American College of Cardiology is a trade association that caters to cardiovascular professionals to learn, grow and share knowledge about cardiovascular care and heart health. It also reviews and offers certification courses focusing on cardiovascular diseases. The association helps in the formation of cardiology guidelines, clinical data standards and health policies. Additionally, it publishes cardiovascular journals which focus on cardiovascular diseases, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented. American College of Cardiology was founded in 1949 and is based in Washington, DC.

Our role in the transaction

Oaklins’ teams in Jacksonville and Savannah acted as financial advisors to MedAxiom in this transaction.

Parties
“We are very pleased with the transaction in all respects. We never could have crossed the finish line without the Oaklins team advising us on tough issues, rolling up their sleeves to keep the deal moving and managing the transaction process.”

Jennifer Linville

Founding CEO, MedAxiom

Talk to the deal team

Bert Tenenbaum

Principal
Savannah, United States
Oaklins Heritage

Doug Kravet

Principal
Jacksonville, United States
Oaklins Heritage

Howard Serkin

Principal
Jacksonville, United States
Oaklins Heritage

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more